Gall Matthew
SEC CIK 1816194 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | CFO | 40.0K | — | — | 1 | 2026-05-01 | 2026-05-01 |
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Beckman Daniella | CFO | — | $126.6K |
| 5 | Ketchum John B | Dir | — | — |
| 6 | Peters Malte | Pres, CEO, Dir | — | — |
| 7 | Rothenberg Mace | Dir | — | — |
| 8 | Gall Matthew | CFO | — | — |
| 9 | Lee Sung | Dir | — | — |
| 10 | Calhoun Lesley Ann | Dir | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 19:46 | 2026-05-01 | TNGX | Tango Therapeutics, Inc. | Gall Matthew | CFO | A - Grant | $0.00 | +40.0K | 40.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations